Подписаться на RSS... cat nikki ... cosmetics used up cat0nikki catonikki ...
Закончилось июнь-Madara,St.Tropez,Natura Siberica,Derma-e.wmv
Forest Laboratories, Inc. and Pierre Fabre Medicament Announce Third Positive ...
Forest Laboratories, Inc. and Pierre Fabre Medicament Announce Positive Phase ...
01.01.70 - MarketWatch (press release)
And Pierre Fabre Medicament today . announced positive top-line results in a Phase III clinical trial of. levomilnacipran, an investigational agent for the treatment of adults. to placebo, as early as week one and at each subsequent visit as. measured by the Montgomery-Asberg Depression Rating Scale-Clinician. treatment of MDD in adults and plan to file a new drug application for. This is the second, positive placebo-controlled Phase. "We have successfully completed two positive Phase III studies for the. Results from an additional placebo-controlled Phase III fixed-dose study. levomilnacipran with the FDA later this year," said Dr. Marco Taglietti,. Senior Vice President, Research & Development and President, Forest. III study in this population. significantly reduced depression...
Источник: MarketWatch (press release)
